Clarendon Fund Managers Limited is a venture capital firm based in Belfast, Northern Ireland, that specializes in investing in small and medium enterprises across various sectors. Established in 2001, the firm focuses primarily on manufacturing and tradable services, preferring to support companies located in Northern Ireland. Clarendon typically invests between £20,000 and £250,000 in initial funding and is open to providing additional financing as needed. The firm has a strategic goal of exiting its investments within five to seven years. Clarendon manages regional venture capital funds, including a significant co-investment fund, and has a robust track record, having invested in over 60 companies since its inception.
Investment Director, Investment Manager and Finance Director
Chris Trotter
Senior Investment Manager
Past deals in Ireland
BrainWaveBank
Seed Round in 2020
BrainWaveBank has developed a first-in-class wearable electroencephalography (EEG) device to conveniently and non-invasively measure the mechanisms that underpin neurological disorders and therapies. Our platform can securely gather, store and analyse data from many thousands of users, building neurocognitive profiles of individuals and populations or demographic groups. This easy-to-scale and distributable approach will help clinical professionals to transform our understanding of brain health and develop the next generation of treatments. BrainWaveBank was founded in January 2015 and has offices in Belfast , Northern Ireland and Dublin, Ireland.
BrainWaveBank
Venture Round in 2020
BrainWaveBank has developed a first-in-class wearable electroencephalography (EEG) device to conveniently and non-invasively measure the mechanisms that underpin neurological disorders and therapies. Our platform can securely gather, store and analyse data from many thousands of users, building neurocognitive profiles of individuals and populations or demographic groups. This easy-to-scale and distributable approach will help clinical professionals to transform our understanding of brain health and develop the next generation of treatments. BrainWaveBank was founded in January 2015 and has offices in Belfast , Northern Ireland and Dublin, Ireland.
See.Sense
Seed Round in 2019
See.Sense develops innovative cycling technology aimed at enhancing safety and convenience for cyclists. The company creates award-winning products that utilize patented sensor technology and artificial intelligence to improve the riding experience. With over 50,000 users globally, See.Sense is recognized as the official bike light and ride insights supplier for British Cycling and Cycling Ireland. The unique data collected by its products supports collaboration with smart cities worldwide, aiming to enhance cycling infrastructure, reduce congestion, and improve urban mobility. The company is based in Northern Ireland and has received multiple awards for its design and innovation.
BrainWaveBank
Seed Round in 2019
BrainWaveBank has developed a first-in-class wearable electroencephalography (EEG) device to conveniently and non-invasively measure the mechanisms that underpin neurological disorders and therapies. Our platform can securely gather, store and analyse data from many thousands of users, building neurocognitive profiles of individuals and populations or demographic groups. This easy-to-scale and distributable approach will help clinical professionals to transform our understanding of brain health and develop the next generation of treatments. BrainWaveBank was founded in January 2015 and has offices in Belfast , Northern Ireland and Dublin, Ireland.
See.Sense
Seed Round in 2018
See.Sense develops innovative cycling technology aimed at enhancing safety and convenience for cyclists. The company creates award-winning products that utilize patented sensor technology and artificial intelligence to improve the riding experience. With over 50,000 users globally, See.Sense is recognized as the official bike light and ride insights supplier for British Cycling and Cycling Ireland. The unique data collected by its products supports collaboration with smart cities worldwide, aiming to enhance cycling infrastructure, reduce congestion, and improve urban mobility. The company is based in Northern Ireland and has received multiple awards for its design and innovation.
BrainWaveBank
Seed Round in 2017
BrainWaveBank has developed a first-in-class wearable electroencephalography (EEG) device to conveniently and non-invasively measure the mechanisms that underpin neurological disorders and therapies. Our platform can securely gather, store and analyse data from many thousands of users, building neurocognitive profiles of individuals and populations or demographic groups. This easy-to-scale and distributable approach will help clinical professionals to transform our understanding of brain health and develop the next generation of treatments. BrainWaveBank was founded in January 2015 and has offices in Belfast , Northern Ireland and Dublin, Ireland.
Autism Biotech
Non Equity Assistance in 2014
Autism Biotech develops biochemical test for the early reliable diagnosis of autism. Autism Biotech's product, ASDtect, a diagnostic test for early and reliable detection of autism spectrum disorder. Based on two fully owned and granted patents for peptide biomarkers for autism, ASDtect targets a huge and untapped market. The company is currently conducting trials and aims to make ASDtect available in the near future. Autism Biotech is headquartered in Belfast, Northern Ireland.
Kelsius
Venture Round in 2012
Kelsius is the supplier of automation technology for product safety and compliance to the food services and healthcare industries. Using the wireless temperature monitoring technology, digital HACCP Management system, and cloud based data hosting and processing, Kelsius systems improve product safety, ensure regulatory compliance, and optimize costs associated with these activities. Kelsius was founded 2003 and is headquartered in Donegal, Ireland
PathXL
Venture Round in 2012
PathXL, a Northern Ireland-based leader in digital pathology image analysis, workflow software and educational tools. PathXL’s image analysis and tissue pathology software will complement Philips’ Digital Pathology Solutions offering, and help expand the business’ leadership in this fast-growing field. Pathology involves the examination of patient tissue samples and plays a crucial role in the diagnosis and treatment of a wide variety of diseases, including cancer.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.